首页> 外文期刊>海南医科大学学报(英文版) >Effect of shexiangbaoxin pill combined with tirofiban hydrochloride on related factors in elderly patients with acute coronary symdrome
【24h】

Effect of shexiangbaoxin pill combined with tirofiban hydrochloride on related factors in elderly patients with acute coronary symdrome

机译:参香保心丸联合盐酸替罗非班对老年急性冠脉综合征患者相关因素的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To study the effect of shexiangbaoxin pill combined with tirofiban hydrochloride on related factors in elderly patients with acute coronary symdrome.Methods:A total of 96 elderly patients with acute coronary symdrome in our hospital from January 2015 to May 2018 were enrolled in this study. The subjects were divided into the control group (n=48) and the treatment group (n=48) randomly. The control group were treated with tirofiban hydrochloride, the treatment group were treated with shexiangbaoxin pill combined with tirofiban hydrochloride, and both the two groups were treated for 2 weeks. The PT, TT, APTT and serum FIB, CK-MB, cTnT, vWF, ET-1, NO, sICAM-1, MMP-9, hs-CRP of the two groups before and after treatment were compared. Results: There were no significantly differences of the PT, TT, APTT and serum FIB, CK-MB, cTnT, vWF, ET-1, NO, sICAM-1, MMP-9, hs-CRP of the two groups before treatment. The PT, TT, APTT and serum NO of the two groups after treatment were significantly higher than before treatment, the serum FIB, vWF, ET, sICAM-1, MMP-9, hs-CRP of the two groups after treatment were significantly lower than before treatment, and that of the treatment group after treatment were significantly better than the control group. The serum CK-MB, cTnT of the two groups after treatment were significantly higher than before treatment, but that of the treatment group after treatment were significantly lower than the control group.Conclusion:Shexiangbaoxin pill combined with tirofiban hydrochloride can significantly improve the blood coagulation function and reduce the Myocardial injury, vascular endothelial damage, inflammation of the elderly patients with acute coronary symdrome, and it was worthy clinical application.
机译:目的:探讨参香保心丸联合盐酸替罗非班对老年急性冠状动脉综合征患者相关因素的影响。方法:2015年1月至2018年5月,本院共纳入96例老年急性冠状动脉综合征患者。 。将受试者随机分为对照组(n = 48)和治疗组(n = 48)。对照组给予盐酸替罗非班治疗,治疗组给予蛇香保心丸联合盐酸替罗非班治疗,两组均治疗2周。比较两组治疗前后的PT,TT,APTT,血清FIB,CK-MB,cTnT,vWF,ET-1,NO,sICAM-1,MMP-9,hs-CRP。结果:治疗前两组的PT,TT,APTT与血清FIB,CK-MB,cTnT,vWF,ET-1,NO,sICAM-1,MMP-9,hs-CRP无明显差异。两组治疗后的PT,TT,APTT和血清NO均显着高于治疗前,两组治疗后的血清FIB,vWF,ET,sICAM-1,MMP-9,hs-CRP均明显降低。与治疗前相比,治疗后治疗组明显优于对照组。两组治疗后血清CK-MB,cTnT均明显高于治疗前,但治疗后治疗组血清CK-MB,cTnT均明显低于对照组。结论:参香保心丸联合盐酸替罗非班可明显改善凝血功能功能和减轻老年急性冠状动脉综合征患者的心肌损伤,血管内皮损伤,炎症反应,值得临床应用。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2019年第005期|P.37-40|共4页
  • 作者单位

    [1]Internal Medicine-Cardiovascular Department,The Sixth Hospital of Wuhan Affiliated Hospital of Jianghan University,Wuhan,430017,Hubei Province,China;

    [1]Internal Medicine-Cardiovascular Department,The Sixth Hospital of Wuhan Affiliated Hospital of Jianghan University,Wuhan,430017,Hubei Province,China;

    [1]Internal Medicine-Cardiovascular Department,The Sixth Hospital of Wuhan Affiliated Hospital of Jianghan University,Wuhan,430017,Hubei Province,China;

    [2]Internal Medicine-Cardiovascular Department,Jiangyin People’s Hospital,Jiangyin,Jiangsu Province,214400,China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 肿瘤学;
  • 关键词

    Acute coronary symdrome; Hydroxyethyl starch injection; Elderly patients; Shexiangbaoxin pill; Tirofiban hydrochloride;

    机译:急性冠状动脉综合征;羟乙基淀粉注射液;老年患者;射香保心丸;盐酸替罗非班;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号